Monday, 28 September 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Aurobindo Pharma Ltd

NSE: AUROPHARMA · BSE: 524804 · Pharmaceuticals & Biotechnology · 10 announcements

Share price: ₹1,712.00
Market cap: ₹99,433 Cr
Revenue (annual): ₹33,653 Cr
Net profit (annual): ₹3,505 Cr
P/E (TTM): 25.2×Sector 50.4×
Promoter holding: 51.88%+0.06% QoQ
FII holding: 16.38%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 4 Financial Results 2 Regulatory Approval 1 Merger & Restructuring 1 Business Update 1 Acquisition 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

5 Aug 2026 19:48 IST NSE

Financial Results

Aurobindo Pharma Q1 FY27 Results: Net Profit ₹1,032 Cr, Up 25.2% YoY

Aurobindo Pharma Ltd reported revenue from operations of ₹9,150 Cr (+16.3% YoY) and net profit of ₹1,032 Cr (+25.2% YoY) for Q1 FY27.

Key figure: Net profit ₹1,032 Cr · +25.2% YoY

Open full results → Read the filing ↗

21 May 2026 19:41 IST NSE

Financial Results

Aurobindo Pharma Q4 FY26 Results: Net Profit ₹920.8 Cr, Up 2.0% YoY

Aurobindo Pharma Ltd reported revenue from operations of ₹8,853 Cr (+5.6% YoY) and net profit of ₹920.8 Cr (+2.0% YoY) for Q4 FY26.

Key figure: Net profit ₹920.8 Cr · +2.0% YoY

Open full results → Read the filing ↗